Azevan Pharmaceuticals

Private

Bethlehem, PennsylvaniaHealthcare & Life Scienceshttps://www.azevan.com/

Last Round

Grant

Mar 1, 2026

Total Funding Raised

$11.6M

Company Overview

Azevan Pharmaceuticals is a biotechnology company that develops novel small-molecule therapeutics to treat stress-related central nervous system disorders and neurodegenerative conditions.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Mental Health

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

biotechnologysmall molecule therapeuticsvasopressin antagonistCNS drug developmentdrug discoveryclinical trialsneurological disorderspsychiatric disordersbiotech startupdrug pipelinepharma licensingmental health therapeuticsbiopharmaclinical-stage company

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Azevan Pharmaceuticals Comps

Public and private peers based on sector, stage, and business model.

Azevan Pharmaceuticals comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Azevan Pharmaceuticals Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Grant	Mar 1, 2026
Series C	Oct 1, 2013

View all Funding Rounds

Azevan Pharmaceuticals Investors

Notable investors and investment history

Azevan Pharmaceuticals investors
Investor	Rounds
United States Department of Defense	Grant
Scientific Health Development	Series C
National Institute of Neurological Disorders and Stroke (NINDS)	Grant
Ascent Biomedical Ventures	Series C
National Institutes of Health (NIH)	Grant

View all Investors

Azevan Pharmaceuticals Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Azevan Pharmaceuticals Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Azevan Pharmaceuticals's valuation, stock price, and market status.

Firmographic Details

HeadquartersBethlehem, Pennsylvania

Employee Range6

Year Founded1999

Last FundingMar 1, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.